Ghost Tree Capital, LLC Geron Corp Transaction History
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
282Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$83.3 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$64.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$59.3 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$49.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$37.6 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $521M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...